AG˹ٷ

STOCK TITAN

[Form 4] Kindly MD, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

David F. Bailey, who is listed as both Chief Executive Officer and a Director of Kindly MD, Inc. (NAKA), reported a transaction dated 08/14/2025 on Form 4. The filing shows an acquisition of 11,160,572 shares of Common Stock at a reported price of $0. Following the transaction, Mr. Bailey is reported to beneficially own 11,160,572 shares in a direct ownership form. The Form 4 is signed by Mr. Bailey on 08/15/2025.

David F. Bailey, indicato sia come Chief Executive Officer sia come Direttore di Kindly MD, Inc. (NAKA), ha dichiarato una transazione datata 14/08/2025 nel modulo Form 4. La comunicazione riporta l'acquisto di 11.160.572 azioni ordinarie a un prezzo dichiarato di $0. Dopo l'operazione, il sig. Bailey risulta titolare beneficiario di 11.160.572 azioni in forma di proprietà diretta. Il Form 4 è firmato dal sig. Bailey in data 15/08/2025.

David F. Bailey, figura como Chief Executive Officer y Director de Kindly MD, Inc. (NAKA), informó una transacción con fecha 14/08/2025 en el Formulario 4. La presentación muestra la adquisición de 11.160.572 acciones ordinarias a un precio declarado de $0. Tras la operación, el Sr. Bailey ostenta la titularidad beneficiaria de 11.160.572 acciones en forma de propiedad directa. El Form 4 está firmado por el Sr. Bailey el 15/08/2025.

David F. Bailey� Kindly MD, Inc. (NAKA)� Chief Executive Officer이자 이사� 등재되어 있으�, 2025-08-14� 거래� Form 4� 보고했습니다. 해당 신고서에� 보통� 11,160,572주를 신고 가� $0� 취득� 것으� 기재되어 있습니다. 거래 � Bailey 씨는 직Ϊ 소유 형태� 11,160,572주의 경제� 실소유자� 보고됩니�. Form 4� 2025-08-15� Bailey 씨가 서명했습니다.

David F. Bailey, désigné à la fois comme Chief Executive Officer et Administrateur de Kindly MD, Inc. (NAKA), a déclaré une transaction datée du 14/08/2025 dans le formulaire Form 4. Le dépôt indique l'acquisition de 11 160 572 actions ordinaires à un prix déclaré de 0 $. À la suite de la transaction, M. Bailey est indiqué comme propriétaire bénéficiaire de 11 160 572 actions en propriété directe. Le Form 4 est signé par M. Bailey le 15/08/2025.

David F. Bailey, der sowohl als Chief Executive Officer als auch als Direktor von Kindly MD, Inc. (NAKA) aufgeführt ist, meldete eine Transaktion vom 14.08.2025 im Formular Form 4. Die Einreichung weist den Erwerb von 11.160.572 Stammaktien zu einem angegebenen Preis von $0 aus. Nach der Transaktion besitzt Herr Bailey nach Angaben 11.160.572 Aktien in Form von direktem Eigentum. Das Form 4 wurde von Herrn Bailey am 15.08.2025 unterschrieben.

Positive
  • Large direct ownership reported: Acquisition and direct beneficial ownership of 11,160,572 shares are disclosed.
  • Clear insider identification: Reporting person is identified as Chief Executive Officer and Director, providing transparency on the acquirer's role.
Negative
  • None.

Insights

TL;DR: CEO David Bailey reported a large direct acquisition of 11,160,572 shares on 08/14/2025.

The filing documents a single non-derivative acquisition of 11,160,572 shares at a reported price of $0, resulting in that same number of shares beneficially owned directly by the reporting person. This is a routine Section 16 disclosure showing insider ownership change; the form does not provide context for the $0 price or the source of the shares.

TL;DR: Insider disclosure shows a material seatbelt on ownership but lacks explanatory detail for the $0 consideration.

The report identifies the reporting person as both CEO and Director and records a direct holding of 11,160,572 shares after an acquisition recorded at $0. The filing contains no explanation of the transaction type (e.g., grant, conversion, or other), so governance implications cannot be fully assessed from this document alone.

David F. Bailey, indicato sia come Chief Executive Officer sia come Direttore di Kindly MD, Inc. (NAKA), ha dichiarato una transazione datata 14/08/2025 nel modulo Form 4. La comunicazione riporta l'acquisto di 11.160.572 azioni ordinarie a un prezzo dichiarato di $0. Dopo l'operazione, il sig. Bailey risulta titolare beneficiario di 11.160.572 azioni in forma di proprietà diretta. Il Form 4 è firmato dal sig. Bailey in data 15/08/2025.

David F. Bailey, figura como Chief Executive Officer y Director de Kindly MD, Inc. (NAKA), informó una transacción con fecha 14/08/2025 en el Formulario 4. La presentación muestra la adquisición de 11.160.572 acciones ordinarias a un precio declarado de $0. Tras la operación, el Sr. Bailey ostenta la titularidad beneficiaria de 11.160.572 acciones en forma de propiedad directa. El Form 4 está firmado por el Sr. Bailey el 15/08/2025.

David F. Bailey� Kindly MD, Inc. (NAKA)� Chief Executive Officer이자 이사� 등재되어 있으�, 2025-08-14� 거래� Form 4� 보고했습니다. 해당 신고서에� 보통� 11,160,572주를 신고 가� $0� 취득� 것으� 기재되어 있습니다. 거래 � Bailey 씨는 직Ϊ 소유 형태� 11,160,572주의 경제� 실소유자� 보고됩니�. Form 4� 2025-08-15� Bailey 씨가 서명했습니다.

David F. Bailey, désigné à la fois comme Chief Executive Officer et Administrateur de Kindly MD, Inc. (NAKA), a déclaré une transaction datée du 14/08/2025 dans le formulaire Form 4. Le dépôt indique l'acquisition de 11 160 572 actions ordinaires à un prix déclaré de 0 $. À la suite de la transaction, M. Bailey est indiqué comme propriétaire bénéficiaire de 11 160 572 actions en propriété directe. Le Form 4 est signé par M. Bailey le 15/08/2025.

David F. Bailey, der sowohl als Chief Executive Officer als auch als Direktor von Kindly MD, Inc. (NAKA) aufgeführt ist, meldete eine Transaktion vom 14.08.2025 im Formular Form 4. Die Einreichung weist den Erwerb von 11.160.572 Stammaktien zu einem angegebenen Preis von $0 aus. Nach der Transaktion besitzt Herr Bailey nach Angaben 11.160.572 Aktien in Form von direktem Eigentum. Das Form 4 wurde von Herrn Bailey am 15.08.2025 unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bailey David F

(Last) (First) (Middle)
5097 SOUTH 900 EAST, SUITE 100

(Street)
SALT LAKE CITY UT 84117

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Kindly MD, Inc. [ NAKA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/14/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/14/2025 A 11,160,572 A $0 11,160,572 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ David Bailey 08/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did David F. Bailey report for Kindly MD (NAKA)?

He reported an acquisition of 11,160,572 shares of Common Stock on 08/14/2025 as disclosed on Form 4.

How many Kindly MD (NAKA) shares does the reporting person beneficially own after the transaction?

11,160,572 shares are reported as beneficially owned following the transaction.

What price was reported for the shares acquired by David F. Bailey on the Form 4?

The reported price is $0 per share as stated in the filing.

What is David F. Bailey's relationship to Kindly MD (NAKA)?

He is reported as Chief Executive Officer and a Director of Kindly MD, Inc.

When was the Form 4 signed by the reporting person?

The signature date on the Form 4 is 08/15/2025.
Kindly Md, Inc.

NASDAQ:NAKA

NAKA Rankings

NAKA Latest News

NAKA Latest SEC Filings

NAKA Stock Data

100.78M
3.92M
48.51%
13.16%
7.08%
Medical Care Facilities
Services-health Services
United States
SALT LAKE CITY